Delivery Order W81K0220D0003-W81K0220F0153
Award Date 10/1/20
Potential Completion Date 9/30/21
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Inseonmedics Inc. has been awarded a $30,850 firm fixed price delivery order for VENTANA HE600 reagents to support the Department of the Army Medical Command's biological defense analytical and archiving capabilities in South Korea. The delivery order exercises the third option year under the Army's indefinite-delivery/indefinite-quantity contract vehicle for laboratory equipment and supplies. No set-aside provisions were applied to this award. The reagents will support continued biological...
- Inseonmedics Inc. was awarded a $20,305 firm-fixed price delivery order against its single-award indefinite delivery contract with the Defense Health Agency to supply VENTANA HE600 reagents for use at the Brian D. Allgood Army Community Hospital laboratory and Biological Defense Automated Analytical Platform in South Korea. The contract, valued at up to $649,470, provides VENTANA HE600 reagents compatible with immunohistochemistry staining platforms to support medical and biological defense...
- The Department of the Army Medical Command awarded a $32,650 firm fixed-price delivery order to Inseonmedics Inc. of South Korea under a blanket purchase agreement for reagents to support the VENTANA HE600 immunohistochemistry staining platform. The reagents will support the U.S. military's laboratory in BDAACH, Korea and must be delivered by September 30, 2020. No set-aside provision was applied to this order to fulfill testing requirements at the Army medical facility in the Republic of...
- This is a federal contract award from the Defense Health Agency (DHA) to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, identified as W81K0220D0003|W81K0224F0054, is for the delivery of VENTANA HE600 reagents, which are critical consumables used in immunohistochemistry staining platforms to support military healthcare and biological defense programs at U.S. military medical facilities in South Korea. The contract is a delivery order under an Indefinite...
- The Defense Health Agency awarded a firm fixed-price purchase order to Inseonmedics Inc. on October 1, 2024, for VENTANA HE600 reagents and related consumables to support the Roche Ventana HE600 Tissue Staining System. The contract has a ceiling value of $121.8K with a base period and four options extending through September 30, 2029. The procurement originated from a sole-source pre-solicitation issued in April 2024 under the statutory authority of FAR 13.106-1(b)(1)(i), which permits awards...
- The Defense Health Agency awarded a $30,586.50 firm fixed-price delivery order to Chenkwang Science for the provision of Biomerieux reagents to support the Biological Defense Analytical and Assessment Center (BDAACH) located in South Korea. The delivery order, effective October 1, 2024, extends through September 30, 2025, and represents one of two firm fixed-price delivery orders issued to the contractor under its larger Indefinite Delivery Contract valued at $232,645.53. Chenkwang Science, a...
- This is a firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Chenkwang Science, a for-profit organization based in South Korea. The $22,774.50 contract is for the delivery of Biomerieux reagents to support biological defense analytical capabilities at U.S. military medical treatment facilities in South Korea, such as Brian Allgood Army Community Hospital and the United States Naval Hospital in Okinawa, Japan. The order has an ultimate completion date of September 30,...
- The Defense Health Agency (DHA) awarded a $33,997.95 firm fixed-price delivery order to Chenkwang Science for Biomerieux reagents supporting the Biological Defense Analytical and Assessment Center. The delivery order, issued on October 1, 2025, is scheduled for completion by September 30, 2026, and represents performance in South Korea. This award was issued under DHA's single-award Indefinite Delivery Contract (IDC) with Chenkwang Science, valued at $232,645.53 and spanning October 1, 2023,...
- The Defense Health Agency awarded a $66,316 delivery order to Synyoung Biomedics, a South Korea-based medical diagnostic equipment supplier, for reagents supporting radiometer arterial blood gas analyzers. This firm fixed-price delivery order, awarded on October 1, 2025, with an ultimate completion date of September 30, 2026, carries no set-aside designation and represents performance to be conducted in South Korea. The award falls under the Defense Health Agency's broader procurement efforts to...
- This is a firm fixed price delivery order contract awarded by the U.S. Department of the Army Medical Command (MEDCOM) to Synyoung Biomedics, a South Korean for-profit company. The contract has a ceiling value of $88,417.00 and is for the delivery of reagents for arterial blood gas analyzers to support the Brian D. Allgood Army Community Hospital in South Korea. This delivery order was issued against a larger, single award indefinite delivery contract with a potential value of $421,130.00 that...
- W81K0220D0003Indefinite Delivery Contract
- W81K0220D0003-W81K0220F0153Delivery Order
This delivery order for $45,000 was awarded by the Department of the Army Medical Command to Inseonmedics Inc. for the second delivery of VENTANA HE600 reagents under Option Period I of an indefinite-delivery/indefinite-quantity contract vehicle. The reagents will support the Biological Defense Automated Analytical Platform located in South Korea. Performance will take place in South Korea and be completed by September 30, 2021. No set-aside designation was applied to this award to supply laboratory consumables for biological defense operations at an overseas medical facility.
Generated 1/2/24, 7:41 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Reagents and Consumable Items for Roche VENTANA HE600 | W81K0220Q0030 | Department of the Army Medical Command | Pre-Solicitation 2/4 | 12/23/19, 1:08 PM | |
Reagents and Consumable Items for Roche VENTANA HE600 | W81K0220Q0030 | Department of the Army Medical Command | Pre-Solicitation 1/4 | 12/2/19, 4:12 PM | |
Reagents and Consumable Items for Roche VENTANA HE600 | W81K0220D0003 | Department of the Army Medical Command | Award Notice 4/4 | 2/13/20, 11:42 AM | |
Reagents and Consumable Items for Roche VENTANA HE600 | W81K0220Q0030 | Department of the Army Medical Command | Solicitation 3/4 | 1/15/20, 4:10 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | $45.0k | 11/3/20 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 10/28/20 | |
| Not listed | Not listed | $0 | 5/12/20 |